Initiative for Medicines, Access & Knowledge
@IMAKglobal
Followers
9K
Following
8K
Statuses
6K
We are a team of lawyers, scientists, and health experts challenging systemic injustice and advocating for health equity in drug development and access.
Joined May 2015
đ¨NEW: We are proud to release our new blueprint presenting policymakers with four approaches and six steps they can take right now to address patent thickets, improve competition in the pharma industry, and lower drug prices. Read the blueprint! ⤾ď¸
0
14
18
RT @realtahiramin: Dems can win back some of the publicâs trust by building an agenda around game-changing ideas *if* they address systemicâŚ
0
2
0
MYTH: More patents, more innovation FACT: More patents does not always mean more innovation
2
1
1
RT @EmmaSands_: 4ď¸âŁ Drug companies abuse the patent system by filing dozens, sometimes hundreds of patents on the same drug to block competâŚ
0
1
0
Read our groundbreaking report on the pharmaceutical industryâs overpatenting tactics.
0
0
1
âPharmaceutical manufacturers often try to justify patent abuse or high prices, citing a need to fund research and development, but the biggest brand name drug companies spend more on marketing and advertising than on R&D." - @RxPricing
1
0
3
RT @realtahiramin: On the left: What Merck is doing around Keytruda On the right: The definition of product hopping and patent evergreeninâŚ
0
2
0
MYTH: To get a patent, you must invent something new FACT: Not all patents are inventive
1
0
3
đ NEW: @cqresearcher report on Americaâs sky-high drug prices details how branded drug companies file high volumes of patents to extend monopoly pricing power and block competition. đ
0
0
1
RT @realtahiramin: Drug prices in the U.S. are: 347% higher than they are in Japan 326% higher than they are in France 294% higher than thâŚ
0
12
0
"As to the [Pharma] industry argument that patients in the United States get the freedom to access drugs first because of the free market, we have to ask: where is the freedom if you can't afford a new drug?" - @realtahiramin
0
1
1
In a sweeping report on drug pricing in the U.S., @cqresearcher explains how drug companiesâ abuse of the patent system drives up prices, citing our analysis of top-selling drugs. đ
0
3
3
MYTH: The private sector is the source of all innovation FACT: Public funding supports a lot of pharmaceutical innovation
0
1
3
RT @linakhanFTC: 1. Today the Federal Circuit rejected Teva's bid to list device patents for inhalers in the Orange Book. Practically thisâŚ
0
3K
0
âThe pharmaceutical industry has way too much power to set prices at will, thanks to their abuse of the patent systemâ đŁď¸ I-MAK CEO @realtahiramin đ
0
0
2
Read @IMAKglobalâs new @politico partnership to understand how the patent system lost its integrity and what it will take to fix it. @SimonTheTam, @snehadave98, @megmon4
0
0
4
RT @ICCRonline: ICCRâs Meg Jones-Monteiro discusses how patent abuse reflects short-term thinkingâsomething investors do not want to see frâŚ
0
1
0
âHow are pharmaceutical companies able to rack up so many patents in the first place that extend their monopolies? The only way to address this abuse is to set a higher bar of inventiveness in order to get a patent.â đŁď¸ I-MAK CEO @realtahiramin đ
0
2
2
We wonât solve the drug pricing problem until we solve the drug patent problem. "Gaming the system: how drug manufacturers use patents to stifle innovation and harm consumersâ âď¸Brian Stanley for @IncidentalEcon
0
1
3
MYTH: Drug companies apply for one patent per drug FACT: Drug companies file dozens or even hundreds of patents on a single drug
0
0
2